DaVita Inc. logo
DaVita Inc. (DVA)
Compare

DaVita Inc. (DVA) EV/EBITDA Ratio: 9.95x

popular:market cap|pe ratio|revenue|price history|total return

Is DaVita Inc.’s EV/EBITDA ratio high or low?

DaVita Inc.'s EV/EBITDA ratio of 9.95x is in line with its 5-year average of 9.40x, around the middle of its 5-year range (8.01x–11.28x).

As of Monday, June 15, 2026. 9.67% above its 12-month average of 9.07x.

EV/Sales|P/E Ratio|EBITDA|All Metrics

DVA EV/EBITDA Ratio Chart

DVA EV/EBITDA Ratio
9.95x+15.03% 1Y
Zoom

DVA Average EV/EBITDA Ratio Chart

DVA Current vs Average EV/EBITDA Ratio Chart

DVA EV/EBITDA Ratio Metrics

EV/EBITDA RATIO

9.95x

EV/EBITDA RATIO AVG TTM

9.07x

EV/EBITDA RATIO AVG 3Y

9.40x

EV/EBITDA RATIO AVG 5Y

9.40x

EV/EBITDA RATIO AVG 10Y

9.37x

EV/EBITDA RATIO AVG 15Y

9.62x

EV/EBITDA RATIO AVG 20Y

9.38x

CURRENT VS TTM AVG

+9.67%

CURRENT VS 3Y AVG

+5.84%

CURRENT VS 5Y AVG

+5.89%

CURRENT VS 10Y AVG

+6.17%

CURRENT VS 15Y AVG

+3.41%

CURRENT VS 20Y AVG

+6.02%

DVA Competitors' EV/EBITDA Ratio

NAMEMARKET CAPEV/EBITDA RATIOTTM3Y5Y
DaVita Inc. (DVA)$13.40B9.95x9.07x9.40x9.40x
The Cooper Companies, Inc. (COO)vs ›$13.24B17.97x15.95x20.14x21.92x
Solventum Corporation (SOLV)vs ›$13.66B6.67x10.13x10.29x10.29x
Align Technology, Inc. (ALGN)vs ›$12.52B13.57x13.18x20.32x25.99x
Baxter International Inc. (BAX)vs ›$10.77B24.95x20.34x19.12x19.11x
Walgreens Boots Alliance, Inc. (WBA)vs ›$10.37BN/A21.34x19.40x19.09x
Hologic, Inc. (HOLX)vs ›$16.97B17.28x15.01x15.35x12.41x
Charles River Laboratories International, Inc. (CRL)vs ›$9.03B41.45x24.46x17.37x18.48x
Tempus AI, Inc. (TEM)vs ›$8.35BN/AN/AN/AN/A
Bio-Rad Laboratories, Inc. (BIO)vs ›$7.73B18.27x11.86x62.18x32.77x

EV/EBITDA vs. its own history

At 9.9, EV/EBITDA is in its normal range, sitting higher than 63% of its 20-year history.

20-year low

5.8

median

9.4

20-year high

14.9

cheaperricher

DaVita Inc. EV/EBITDA Ratio Formula & Definition

EV/EBITDA = Enterprise Value / EBITDA (TTM)

Enterprise value to EBITDA is a capital-structure-neutral valuation multiple, useful for comparing companies with different debt levels and tax rates.

Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute

DaVita Inc. EV/EBITDA Ratio FAQ

What is the EV/EBITDA ratio for DaVita Inc. (DVA)?
The EV/EBITDA ratio for DVA stock is 9.95x.
Is DaVita Inc.'s EV/EBITDA ratio high or low?
DaVita Inc.'s EV/EBITDA ratio of 9.95x is in line with its 5-year average of 9.40x, around the middle of its 5-year range (8.01x–11.28x).
What is the TTM average EV/EBITDA ratio for DaVita Inc. (DVA)?
The TTM average EV/EBITDA ratio for DVA stock is 9.07x.
What is the 3Y average EV/EBITDA ratio for DaVita Inc. (DVA)?
The 3Y average EV/EBITDA ratio for DVA stock is 9.40x.
What is the 5Y average EV/EBITDA ratio for DaVita Inc. (DVA)?
The 5Y average EV/EBITDA ratio for DVA stock is 9.40x.
What is the 10Y average EV/EBITDA ratio for DaVita Inc. (DVA)?
The 10Y average EV/EBITDA ratio for DVA stock is 9.37x.
What is the 15Y average EV/EBITDA ratio for DaVita Inc. (DVA)?
The 15Y average EV/EBITDA ratio for DVA stock is 9.62x.
What is the 20Y average EV/EBITDA ratio for DaVita Inc. (DVA)?
The 20Y average EV/EBITDA ratio for DVA stock is 9.38x.

DaVita Inc. EV/EBITDA Ratio History

DATEEV/EBITDA RATIO
2026-06-129.95x
2026-06-119.83x
2026-06-109.69x
2026-06-099.69x
2026-06-089.53x
2026-06-059.53x
2026-06-049.53x
2026-06-039.60x
2026-06-029.42x
2026-06-019.47x
2026-05-299.59x
2026-05-289.66x
2026-05-279.60x
2026-05-269.62x
2026-05-229.69x
2026-05-219.70x
2026-05-209.65x
2026-05-199.59x
2026-05-189.72x
2026-05-159.72x
2026-05-149.54x
2026-05-139.68x
2026-05-129.74x
2026-05-119.70x
2026-05-089.70x
2026-05-079.64x
2026-05-069.58x
2026-05-058.64x
2026-05-0410.55x
2026-05-0110.47x
2026-04-3010.58x
2026-04-2910.48x
2026-04-2810.41x
2026-04-2710.41x
2026-04-2410.47x
2026-04-2310.58x
2026-04-2210.49x
2026-04-2110.41x
2026-04-2010.39x
2026-04-1710.34x
2026-04-1610.35x
2026-04-1510.23x
2026-04-1410.39x
2026-04-1310.46x
2026-04-1010.41x
2026-04-0910.43x
2026-04-0810.36x
2026-04-0710.40x
2026-04-0610.42x
2026-04-0210.26x
2026-04-0110.42x
2026-03-3110.53x
2026-03-3010.49x
2026-03-2710.56x
2026-03-2610.64x
2026-03-2510.58x
2026-03-2410.52x
2026-03-2310.48x
2026-03-2010.39x
2026-03-1910.40x
2026-03-1810.37x
2026-03-1710.41x
2026-03-1610.35x
2026-03-1310.44x
2026-03-1210.51x
2026-03-1110.57x
2026-03-1010.46x
2026-03-0910.50x
2026-03-0610.44x
2026-03-0510.41x
2026-03-0410.57x
2026-03-0310.49x
2026-03-0210.54x
2026-02-2710.62x
2026-02-2610.50x
2026-02-2510.39x
2026-02-2410.44x
2026-02-2310.45x
2026-02-2010.44x
2026-02-1910.32x
2026-02-1810.34x
2026-02-1710.42x
2026-02-1310.38x
2026-02-1210.41x
2026-02-1110.22x
2026-02-109.22x
2026-02-099.18x
2026-02-069.26x
2026-02-059.50x
2026-02-049.30x
2026-02-039.10x
2026-02-028.44x
2026-01-308.39x
2026-01-298.33x
2026-01-288.29x
2026-01-278.28x
2026-01-268.34x
2026-01-238.35x
2026-01-228.38x
2026-01-218.30x
2026-01-208.24x
2026-01-168.26x
2026-01-158.29x
2026-01-148.24x
2026-01-138.25x
2026-01-128.41x
2026-01-098.45x
2026-01-088.48x
2026-01-078.44x
2026-01-068.54x
2026-01-058.52x
2026-01-028.53x
2025-12-318.51x
2025-12-308.51x
2025-12-298.50x
2025-12-268.52x
2025-12-248.53x
2025-12-238.54x
2025-12-228.59x
2025-12-198.55x
2025-12-188.58x
2025-12-178.64x
2025-12-168.63x
2025-12-158.69x
2025-12-128.72x
2025-12-118.69x
2025-12-108.65x
2025-12-098.59x
2025-12-088.60x
2025-12-058.61x
2025-12-048.61x
2025-12-038.64x
2025-12-028.66x
2025-12-018.66x
2025-11-288.68x
2025-11-268.69x
2025-11-258.72x
2025-11-248.67x
2025-11-218.69x
2025-11-208.56x
2025-11-198.55x
2025-11-188.59x
2025-11-178.61x
2025-11-148.73x
2025-11-138.77x
2025-11-128.79x
2025-11-118.75x
2025-11-108.69x
2025-11-078.79x
2025-11-068.73x
2025-11-058.72x
2025-11-048.68x
2025-11-038.66x
2025-10-318.66x
2025-10-308.65x
2025-10-298.87x
2025-10-288.17x
2025-10-278.17x
2025-10-248.16x
2025-10-238.12x
2025-10-228.15x
2025-10-218.14x
2025-10-208.13x
2025-10-178.06x
2025-10-168.05x
2025-10-158.07x
2025-10-148.08x
2025-10-138.01x
2025-10-108.01x
2025-10-098.08x
2025-10-088.12x
2025-10-078.21x
2025-10-068.13x
2025-10-038.21x
2025-10-028.24x
2025-10-018.26x
2025-09-308.26x
2025-09-298.20x
2025-09-268.20x
2025-09-258.19x
2025-09-248.28x
2025-09-238.26x
2025-09-228.21x
2025-09-198.19x
2025-09-188.19x
2025-09-178.12x
2025-09-168.18x
2025-09-158.21x
2025-09-128.27x
2025-09-118.27x
2025-09-108.25x
2025-09-098.37x
2025-09-088.31x
2025-09-058.41x
2025-09-048.34x
2025-09-038.35x
2025-09-028.38x
2025-08-298.40x
2025-08-288.35x
2025-08-278.40x
2025-08-268.43x
2025-08-258.39x
2025-08-228.48x
2025-08-218.40x
2025-08-208.39x
2025-08-198.37x
2025-08-188.27x
2025-08-158.33x
2025-08-148.31x
2025-08-138.32x
2025-08-128.24x
2025-08-118.15x
2025-08-088.17x
2025-08-078.12x
2025-08-068.12x
2025-08-058.48x
2025-08-048.72x
2025-08-018.68x
2025-07-318.74x
2025-07-308.87x
2025-07-298.91x
2025-07-288.89x
2025-07-258.89x
2025-07-248.88x
2025-07-239.08x
2025-07-228.91x
2025-07-218.71x
2025-07-188.77x
2025-07-178.83x
2025-07-168.74x
2025-07-158.75x
2025-07-148.83x
2025-07-118.81x
2025-07-108.84x
2025-07-098.79x
2025-07-088.85x
2025-07-078.82x
2025-07-038.81x
2025-07-028.81x
2025-07-018.94x
2025-06-308.81x
2025-06-278.78x
2025-06-268.76x
2025-06-258.74x
2025-06-248.76x
2025-06-238.62x
2025-06-208.64x
2025-06-188.60x
2025-06-178.62x
2025-06-168.66x
2025-06-138.61x
2025-06-128.65x
2025-06-118.67x
2025-06-108.70x
2025-06-098.66x
2025-06-068.67x
2025-06-058.66x
2025-06-048.63x
2025-06-038.61x
2025-06-028.56x

Showing the most recent 260 of 5,033 data points. The chart above shows the full history.

Related Metrics

EV/SalesP/E RatioEBITDAAll Metrics

About DaVita Inc.

DaVita Inc. specializes in delivering essential kidney dialysis treatments and comprehensive renal care to individuals grappling with chronic kidney failure. The company primarily operates an extensive network of outpatient dialysis centers, supplementing this with services provided in hospital inpatient settings and within patients' homes. Beyond direct patient treatment, DaVita manages its own diagnostic laboratories, performing routine tests vital for dialysis patients, alongside other physician-ordered laboratory analyses specifically for those with end-stage renal disease (ESRD). The firm also offers administrative and management support to various other outpatient dialysis facilities. Its broad spectrum of offerings extends to chronic disease management programs, supporting a substantial patient cohort; by year-end 2021, this included 16,000 patients enrolled in risk-based integrated care models and an additional 7,000 in other integrated care arrangements. Further specialized services encompass vascular access interventions, clinical research initiatives, direct physician support, and a complete suite of holistic kidney care solutions. As of December 31, 2021, DaVita's footprint across the United States comprised 2,815 outpatient dialysis centers, collectively serving approximately 203,100 patients. Globally, the company operated 339 outpatient dialysis centers spread across ten countries outside the U.S., attending to roughly 39,900 patients. Moreover, it furnished acute inpatient dialysis services and related laboratory work in around 850 U.S. hospitals. Founded in 1994, DaVita Inc. maintains its headquarters in Denver, Colorado. The company rebranded to its current name in September 2016, having previously been known as DaVita HealthCare Partners Inc.

Denver, CO
76,000 employees
www.davita.com
Healthcare / Medical - Care Facilities
Sector
Healthcare
Industry
Medical - Care Facilities
CEO
Javier J. Rodriguez
View full financials